Article Details
Retrieved on: 2021-07-16 04:37:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“We're also watching Neuren Pharma (ASX:NEU) very closely as they're expecting the recruitment for their Phase II trial to be finished very shortly,” ...
Article found on: stockhead.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here